Fennec Pharmaceuticals Inc. (FENC) Social Stream
FENNEC PHARMACEUTICALS INC (FENC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering FENC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 5 | $17 | $12 | $13.6 | $10.42 | 30.52% |
| 2021-11-29 | 5 | $17 | $9 | $13 | $10.42 | 24.76% |
| 2021-11-30 | 5 | $17 | $7 | $11.8 | $10.42 | 13.24% |
| 2022-01-03 | 5 | $17 | $7 | $11.4 | $10.42 | 9.4% |
| 2022-02-28 | 4 | $17 | $7 | $11.6 | $10.42 | 11.32% |
| 2022-04-27 | 4 | $14 | $7 | $10.25 | $10.42 | -1.63% |
| 2022-06-02 | 2 | $11 | $7 | $9.333 | $10.42 | -10.43% |
| 2022-06-03 | 3 | $11 | $7 | $9.333 | $10.42 | -10.43% |
| 2022-08-08 | 3 | $14 | $7 | $10.5 | $10.42 | 0.77% |
| 2022-08-12 | 4 | $14 | $7 | $10.5 | $10.42 | 0.77% |
| 2022-09-07 | 5 | $14 | $7 | $10.6 | $10.42 | 1.73% |
| 2022-09-22 | 5 | $14 | $9 | $11 | $10.42 | 5.57% |
| 2022-09-26 | 5 | $19 | $9 | $12.6 | $10.42 | 20.92% |
| 2022-09-30 | 5 | $19 | $9 | $13.6 | $10.42 | 30.52% |
| 2022-10-18 | 5 | $19 | $9 | $14.6 | $10.42 | 40.12% |
| 2022-10-20 | 6 | $19 | $9 | $15.166 | $10.42 | 45.55% |
| 2022-11-22 | 6 | $19 | $12 | $15.666 | $10.42 | 50.35% |
| 2023-03-31 | 6 | $18 | $12 | $15.333 | $10.42 | 47.15% |
| 2023-04-04 | 6 | $18 | $12 | $15.166 | $10.42 | 45.55% |
| 2023-05-15 | 6 | $18 | $14 | $15.833 | $10.42 | 51.95% |
| 2023-08-03 | 5 | $18 | $14 | $15.833 | $10.42 | 51.95% |
| 2023-08-04 | 5 | $17 | $14 | $15.666 | $10.42 | 50.35% |
| 2023-11-07 | 6 | $17 | $15 | $16 | $10.42 | 53.55% |
The Trend in the Analyst Price Target
FENC's average price target has moved up $6.67 over the prior 17 months.
FENC reports an average of 90.47% for its upside potential over the past 41 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-31 | 6 | 18 | 12 | 15.333 | 8.32 | 84.29% |
| 2023-05-15 | 5 | 18 | 14 | 15.833 | 7.64 | 107.24% |
| 2023-08-04 | 5 | 17 | 14 | 15.666 | 8.03 | 95.09% |
| 2023-08-04 | 4 | 17 | 16 | 16.250 | 8.03 | 102.37% |
| 2023-08-04 | 4 | 17 | 15 | 16.000 | 8.03 | 99.25% |
FENC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 6 | 0 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
FENC's average broker recommendation rating improved by 0 over the prior 41 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- FENC has a greater average analyst price target than 433.65% of all US stocks.
- FENNEC PHARMACEUTICALS INC's number of analysts covering the stock is greater than 528.39% of all US stocks.
- In terms of how FENNEC PHARMACEUTICALS INC fares relative to stocks in the micro market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 602.03% of that group.
- In terms of how FENNEC PHARMACEUTICALS INC fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -1095.9% of that group.
Stocks similar to FENNEC PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IKT, TCRX, and PMCB.
View All Top Stocks by Price Target
Is FENC a Buy, Hold or Sell? See the POWR Ratings now!